Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc. 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8026-02.
Published January 22, 2025 · Recall initiated: December 12, 2024
Summary
FDA records drug Class III recall D-0199-2025, published January 22, 2025 and initiated December 12, 2024. Recalling firm: Akron Pharma, Inc.; Status: Ongoing; Reported quantity: 324 bottles; Lot: Lot: KDC0224001B Exp 09/30/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Akron Pharma, Inc.
- Distributor
- Nationwide in the US
- Lot
- Lot: KDC0224001B Exp 09/30/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADiphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373January 22, 2025
- FDAAcetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E,January 22, 2025
- FDADiphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RTJanuary 22, 2025
- FDAAcetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc.,January 22, 2025
- FDASystane Lubricant Eye Drops, Ultra PF, Sterile, 25 Vials (0.7mL Each), Manufactured for: Alcon Laboratories,January 22, 2025
- FDAClobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, AmnealJanuary 22, 2025
Questions about this recall
Was Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc. 373 Route US 46, Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8026-02. recalled?
Yes. FDA published recall D-0199-2025 on January 22, 2025. Reported hazard: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
What should I do if I have this product?
Voluntary: Firm initiated · Letter